2017
DOI: 10.1074/jbc.m116.746859
|View full text |Cite
|
Sign up to set email alerts
|

Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17

Abstract: We previously showed that the cell adhesion molecule Nectin-4 is overexpressed in ovarian cancer tumors, and its cleaved extracellular domain can be detected in the serum of ovarian cancer patients. The ADAM (isintegrin ndetalloproteinase) proteases are involved in ectodomain cleavage of transmembrane proteins, and ADAM17 is known to cleave Nectin-4 in breast cancer. However, the mechanism of Nectin-4 cleavage in ovarian cancer has not yet been determined. Analysis of ovarian cancer gene microarray data showed… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
48
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 53 publications
(52 citation statements)
references
References 68 publications
0
48
0
Order By: Relevance
“…Blocking ADAM17 may decrease the inhibitory effects of soluble NKG2D ligands and increase NKG2D binding to its ligands on tumor cells. In addition, ADAM17 has been shown to be overexpressed in cancer cells and cause their release of EGFR ligands and adhesion molecules that promote growth and metastasis . Taken together, blocking ADAM17 activity may impair tumor cell growth and survival in various direct and indirect manners.…”
Section: Adam17 As a Regulatory Checkpoint Of Adcc By Nk Cellsmentioning
confidence: 99%
See 3 more Smart Citations
“…Blocking ADAM17 may decrease the inhibitory effects of soluble NKG2D ligands and increase NKG2D binding to its ligands on tumor cells. In addition, ADAM17 has been shown to be overexpressed in cancer cells and cause their release of EGFR ligands and adhesion molecules that promote growth and metastasis . Taken together, blocking ADAM17 activity may impair tumor cell growth and survival in various direct and indirect manners.…”
Section: Adam17 As a Regulatory Checkpoint Of Adcc By Nk Cellsmentioning
confidence: 99%
“…There have been broad efforts to develop ADAM17 inhibitors, with a particular focus on preventing tumor cell growth and spread . Initial efforts were on the development of selective small‐molecule inhibitors.…”
Section: Adam17 As a Regulatory Checkpoint Of Adcc By Nk Cellsmentioning
confidence: 99%
See 2 more Smart Citations
“…This can include uncontrolled cellular growth and metastasis (Adorno‐Cruz & Liu, 2019). Indeed, much of what is known about adhesion molecules and cellular function has come from studies in cancer biology (Buchanan et al, 2017; Edwards, Handsley, & Pennington, 2008; Najy, Day, & Day, 2008; Shiomi, Lemaitre, D'Armiento, & Okada, 2010; Sousa, Pereira, & Paredes, 2019; Zadka, Kulus, & Piatek, 2018).…”
Section: Introductionmentioning
confidence: 99%